ACM
PMVP icon

ADAR1 Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

ADAR1 Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$286K Buy
231,008
+130,000
+129% +$165K 0.02% 241
2025
Q4 		$126K Hold
101,008
– – 0.01% 244
2025
Q3 		$141K Hold
101,008
– – 0.01% 194
2025
Q2 		$107K Hold
101,008
– – 0.02% 173
2025
Q1 		$110K Hold
101,008
– – 0.02% 162
2024
Q4 		$153K Hold
101,008
– – 0.03% 168
2024
Q3 		$151K Buy
101,008
+51,008
+102% +$78.8K 0.02% 176
2024
Q2 		$81K Buy
50,000
+40,000
+400% +$72.1K 0.02% 175
2024
Q1 		$17K Buy
+10,000
New +$18.7K ﹤0.01% 221

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ADAR1 Capital Management's PMVP Position: Q1 2026 in Review

ADAR1 Capital Management increased its PMV Pharmaceuticals (PMVP) stake by 129% in Q1 2026, buying an estimated $165K and bringing the position to 231,008 shares worth $286K. The position accounts for 0.02% of the portfolio, ranked #241.

ADAR1 Capital Management first reported a position in PMVP in Q1 2024 and has held it in 9 quarters since. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • ADAR1 Capital Management held 231,008 shares of PMV Pharmaceuticals worth $286K as of Q1 2026.
  • ADAR1 Capital Management bought 130,000 PMV Pharmaceuticals shares in Q1 2026, an estimated $165K.
  • PMV Pharmaceuticals made up 0.02% of ADAR1 Capital Management's portfolio in Q1 2026, its #241 holding.
  • ADAR1 Capital Management first reported a position in PMV Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.